Citations

Showing 10 of 108152 citations.

Credibility assessment of patient-specific biomechanical models to investigate proximal junctional failure in clinical cases with adult spine deformity using ASME V&V40 standard
Poncelas, Maeva Lopez , Barbera, Luigi La , Rawlinson, Jeremy , Crandall, Dennis G. , Aubin, Carl‐Éric , Lopez Poncelas, M , La Barbera, L , Rawlinson, J J , Crandall, D , Aubin, C E

Mayo Clinic

Computer Methods in Biomechanics and Biomedical Engineering | August 24, 2021 | Volume: 25 | Issue: 5 | Pages: 543-553

10.1080/10255842.2021.1968380 | PMID 34427119 Get It

All You Need To Know and More about the Diagnosis and Management of Rare Yeast Infections
Sprute, Rosanne , Cornely, Oliver A. , Chen, Sharon C.‐A. , Schuetz, Audrey N. , Zhang, Sean X. , Schuetz, Audrey N , Zhang, Sean X , Cornely, Oliver A , Seidel, Danila

Mayo Clinic

mBio | August 24, 2021 | Volume: 12 | Issue: 4 | Pages: No page available

10.1128/mbio.01594-21 | PMID 34425700 Get It

Invasive infections with emerging yeasts such asGeotrichum,Saprochaete/Magnusiomyces, Trichosporon, and other species are associated with high morbidity and mortality rates. Due to the rarity and heterogeneity of these yeasts, medical mycology has lacked guidance in critical areas affecting patient management.
Extent of eosinophilic esophagitis predicts response to treatment
Ghoz, Hassan , Valery, Jose R. , Nordelo, Katie, Malviya, Balkishan, Lacy, Brian E. , Francis, Dawn L., DeVault, Kenneth R. , Bouras, Ernest P., Krishna, Murli , Palmer, William C. , Francis, Dawn, DeVault, Kenneth, Bouras, Ernest, Stancampiano, Fernando F. , Lacy, Brian E.

Mayo Clinic

Endoscopy International Open | August 24, 2021 | Volume: 09 | Issue: 08 | Pages: E1234-E1242

10.1055/a-1492-2650 | PMID 34447870 Get It

Abstract Background and study aim The clinical impact of eosinophilic esophagitis (EoE) limited to the distal esophagus (Lim-EE) vs. diffuse involvement (Dif-EE) is unknown. This study compared clinical characteristics and outcomes of Lim-EE vs. Dif-EE. Patients and methods This retrospective, single-center study of patients with EoE between December 2011 and December 2019 evaluated treatment response based on repeated pathology and/or clinical improvement using comparative statistics. Results 479 patients were identified (126 Lim-EE, 353 Dif-EE). Lim-EE patients had a higher incidence of endoscopically identified esophagitis (23.0 % vs. 14.7 %; P = 0.04), were older (50.8 [SD 16.2] vs. 46.4 [SD 15.3] years; P = 0.007), and were more likely to present with iron deficiency anemia (5.6 % vs. 1.7 %; P = 0.05), dyspepsia (15.1 % vs. 8.8 %; P = 0.06) or for Barrett’s surveillance (10.3 % vs. 3.7 %; P = 0.02). Patients with Dif-EE presented more frequently with dysphagia (57.2 % vs. 45.2 %; P = 0.02). Both groups had similar proton pump inhibitor (87.2 % vs. 83.3 %; P = 0.37) and steroid (12.8 % vs. 21.4 %; P = 0.14) use. Patients with Lim-EE had a better clinicopathologic response (61.5 % vs. 44.8 %; P = 0.009). On multivariate analysis, EoE extent predicted treatment response with an odds ratio of 1.89 (95 % confidence interval 1.13–3.20; P = 0.02). However, treatment response based only on repeat biopsy results showed no statistical difference between Lim-EE (52.5 %) and Dif-EE (39.7 %; P = 0.15). Conclusions Lim-EE may represent a distinct phenotype separate from Dif-EE, with more overlap with gastroesophageal reflux disease and better treatment response.
Short versus standard esophageal myotomy in achalasia patients: a systematic review and meta-analysis of comparative studies
Khan, Shahab R. , Ramai, Daryl , Dhindsa, Banreet, Kassab, Lena L., Goyal, Hemant , Bhat, Ishfaq , Singh, Shailender, McDonough, Stephanie, Chandan, Saurabh , Facciorusso, Antonio , Mohan, Babu P. , Bilal, Mohammad , Perisetti, Abhilash , Adler, Douglas G.

Mayo Clinic

Endoscopy International Open | August 24, 2021 | Volume: 09 | Issue: 08 | Pages: E1246-E1254

10.1055/a-1490-8493 | PMID 34447872 Get It

Abstract Background and study aims Despite the clinical efficacy of peroral endoscopic myotomy (POEM), postoperative symptomatic gastroesophageal reflux disease (GERD) remains a major concern. While it is known that length of the gastric myotomy affects postoperative GERD, the clinical relevance of variation in esophageal myotomy length is not well known. We performed a systematic review and meta-analysis of studies comparing outcomes of short versus standard myotomy length in patients with achalasia. Patients and methods We searched multiple databases from inception through November 2020 to identify studies that reported on outcomes of achalasia patients who underwent short compared with standard esophageal myotomy. Meta-analysis was performed to determine pooled odds ratio (OR) of clinical success, GERD outcomes, and adverse events with the two techniques. Results 5 studies with 474 patients were included in the final analysis (short myotomy group 214, standard myotomy group 260). There was no difference in clinical success (OR 1.17, 95 % confidence interval [CI] 0.54–2.52; I2 0 %; P = 0.69), postoperative symptomatic GERD (OR 0.87, 95 %CI 0.44–1.74; I2 29 %; P = 0.70), and overall adverse events (OR 0.52, 95 %CI 0.19–1.38; I2 40 %; P = 0.19), between the two groups. Incidence of postoperative erosive esophagitis as determined by endoscopy was lower in the short myotomy group (OR 0.50, 95 %CI 0.24–1.03; I2 0 %; P = 0.06). Conclusion Our analysis showed that performing POEM with short esophageal myotomy in achalasia was as safe and effective as standard myotomy, with lower incidence of postoperative erosive esophagitis.
Scissor-type knife improves the safety of endoscopic submucosal dissection (ESD) among endoscopists without experience in ESD: a randomized ex vivo study
Visrodia, Kavel , Sawas, Tarek , Zakko, Liam , Lutzke, Lori S., Wang, Kenneth K. , Leggett, Cadman, Lutzke, Lori, Sawas, T , Genere, Juan Reyes , Leggett, Cadman L.

Mayo Clinic

Endoscopy International Open | August 24, 2021 | Volume: 09 | Issue: 08 | Pages: E1207-E1213

10.1055/a-1487-5469 | PMID 34447866 Get It

AbstractBackground and study aims Endoscopic submucosal dissection (ESD) is technically challenging, difficult to learn, and carries a substantial risk of perforation, all of which remain significant barriers to its adoptability. We aimed to determine whether use of a novel scissor-type knife improved efficacy and safety among novice performers of ESD.Materials and methods Following a brief didactic session on ESD, participants performed ESD of two lesions (2 cm diameter) in an ex vivo porcine gastric model. One resection was performed with a conventional knife and the other with the scissor knife (order of knife randomized). We recorded procedure time, successful en bloc resection, and adverse events (including full-thickness perforation and muscle injury) for each dissection. Participants completed a post-study survey.Results 10 endoscopists (8 trainees, 2 staff) considered novices in ESD participated. Compared with the conventional knife, use of the scissor knife was associated with a significantly shorter time to completion of submucosal dissection (mean 6.2 [SD 5.6] vs. 15.6 [SD 15.6] minutes; P = 0.04) and total procedure time was not significantly different (22.1 [SD 13.3] vs. 24.9 [SD 26.5] minutes; P = 0.65). Scissor knife use was also associated with a significantly lower proportion of perforation and/or muscle injury (10.0 % vs. 70.0 %; P < 0.01) and proportion of muscle injury alone (10.0 % vs. 60.0 %; P = 0.02).Conclusions Among novices performing ESD on an ex vivo animal model, use of a scissor knife was associated with a significantly lower proportion of adverse events without prolonging procedure time. Scissor-type knives may improve ESD safety, at least among novices.
Follow-up after EUS-guided radiofrequency ablation for pancreatic lesions: With more answers, come more questions
Law, Ryan , Levy, Michael J. , Levy, Michael J.

Mayo Clinic

Endoscopy International Open | August 24, 2021 | Volume: 09 | Issue: 08 | Pages: E1186-E1187

10.1055/a-1393-5780 | PMID 34447861 Get It

Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure
Paneni, Francesco , Mazzola, Matteo , Biase, Nicolò De , Punta, Lavinia Del, Gargani, Luna , Mengozzi, Alessandro , Nesti, Lorenzo , Flammer, Andreas J. , Paneni, Francesco , Pugliese, Nicola Riccardo , Virdis, Agostino , Taddei, Stefano , Borlaug, Barry A. , Ruschitzka, Frank T. , Masi, Stefano

Mayo Clinic

European Journal of Heart Failure | August 24, 2021 | Volume: 23 | Issue: 11 | Pages: 1858-1871

10.1002/ejhf.2337 | PMID 34427016 Get It

Abstract Aims We evaluated the impact of echocardiographic epicardial adipose tissue (EAT) on cardiovascular haemodynamics, metabolic profile and prognosis in heart failure (HF) using combined cardiopulmonary‐echocardiography exercise stress. Methods and results We analysed EAT thickness of HF patients with reduced (HFrEF, n = 205) and preserved (HFpEF, n = 188) ejection fraction, including 44 controls. HFpEF patients displayed the highest EAT, while HFrEF patients had lower values than controls. EAT showed an inverse correlation with natriuretic peptides, troponin T and C‐reactive protein in HFrEF, while having a direct association with troponin T and C‐reactive protein in HFpEF. EAT was independently associated with peak oxygen consumption (VO 2 ) and peripheral extraction (AVO 2 diff), regardless of body mass index. EAT was inversely correlated with peak VO 2 and AVO 2 diff in HFpEF, while a direct association was observed in HFrEF, where lower EAT values were associated with worse left ventricular systolic dysfunction. In HFpEF, increased EAT was related to right ventriculo–arterial (tricuspid annular plane systolic excursion/systolic pulmonary artery pressure) uncoupling. After 21 months of follow‐up, 146 HF hospitalizations and 34 cardiovascular deaths were recorded in the HF population. Cox multivariable analysis supported an independent differential role of EAT in HF cohorts (interaction P = 0.01): higher risk of adverse events for increasing EAT in HFpEF [hazard ratio (HR) 1.12, 95% confidence interval (CI) 1.04–1.37] and for decreasing EAT in HFrEF (HR 0.75, 95% CI 0.54–0.91). Conclusion In HFpEF, EAT accumulation is associated with worse haemodynamic and metabolic profile, also affecting survival. Conversely, lower EAT values imply higher left ventricular dysfunction, global functional impairment and adverse prognosis in HFrEF.
Gray and White Matter Correlates of Dysphagia in Progressive Supranuclear Palsy
Tosakulwong, Nirubol , Weigand, Stephen D. , Ali, Farwa , Pham, Nha Trang Thu, Senjem, Matthew L. , Jack, Clifford R. , Lowe, Val J. , Ahlskog, J. Eric , Josephs, Keith A. , Whitwell, Jennifer L. , Josephs, Keith A , Whitwell, Jennifer , Jack, Clifford R , Senjem, Matthew L , Clark, Heather M. , Botha, Hugo , Schwarz, Christopher G. , Reid, Robert I.

Mayo Clinic

Movement Disorders | August 24, 2021 | Volume: 36 | Issue: 11 | Pages: 2669-2675

10.1002/mds.28731 | PMID 34426998 Get It

AbstractBackgroundDysphagia is a common symptom of progressive supranuclear palsy often leading to aspiration pneumonia and death.ObjectiveThe aim of this study was to examine how impairments of the oral and pharyngeal phases of the swallow and airway incursion during liquid swallows relate to gray and white matter integrity.MethodsThirty‐eight participants with progressive supranuclear palsy underwent videofluorographic swallowing assessment and structural and diffusion tensor head magnetic resonance imaging. Penalized linear regression models assessed relationships between swallowing metrics and regional gray matter volumes and white matter fractional anisotropy and mean diffusivity.ResultsOral phase impairments were associated with reduced superior parietal volumes and abnormal diffusivity in parietal and sensorimotor white matter, posterior limb of the internal capsule, and superior longitudinal fasciculus. Pharyngeal phase impairments were associated with disruption to medial frontal lobe, corticospinal tract, and cerebral peduncle. No regions were predictive of airway incursion.ConclusionsDifferential patterns of neuroanatomical impairment corresponded to oral and pharyngeal phase swallowing impairments. © 2021 International Parkinson and Movement Disorder Society
Risk of bleeding following double balloon enteroscopy in patients on continued antiplatelet and/or anticoagulation therapy
Zaver, Himesh B. , Ghoz, Hassan , Alnahhal, Khaled I. , Malviya, Balkishan, Patel, Krupa , Rodriguez, Andrea C. , Oberoi, Mansi , Koralewski, Andrea, Crawford, Matthew James , Choudhry, Aruj, Mareth, Karl , Werlang, Monia E., Lukens, Frank , Stark, Mark E., Brahmbhatt, Bhaumik , Stancampiano, Fernando, Crawford, Matthew J, Stark, Mark, Stancampiano, Fernando F. , Kröner, Paul T. , Simons-Linares, C. Roberto , Bartel, Michael J.

Mayo Clinic

Endoscopy International Open | August 23, 2021 | Volume: 09 | Issue: 09 | Pages: E1397-E1403

10.1055/a-1499-6988 | PMID 34466365 Get It

Abstract Background and study aims Anticoagulation (AC) and antiplatelet (AP) therapy may increase the risk of gastrointestinal bleeding after double balloon enteroscopy (DBE); however, limited data are currently available regarding the incidence. The aim of this study was to assess the incidence and clinical characteristics of post-DBE bleeding in patients on AC and AP therapy. Patients and methods The medical records of patients who underwent DBE between 2009 and 2013 at Mayo Clinic, Florida, were retrospectively reviewed. Patients were divided into three groups: 1) continued AP therapy; 2) AC therapy; and 3) neither AP nor AC at the time of DBE. Follow-up data were collected at 60 days and 1 year. Results A total of 683 patients were identified; 43 on AC, 183 on AP and 457 not on AP or AC therapy. The most common indication for DBE was obscure gastrointestinal bleeding in the groups on and not on AP (85.3 % vs 70.9 %, P < 0.0001). There was no statistical difference in post-DBE bleeding rates in patients on AP vs not on AP at 60 days (11.5 % vs 7.5 %, P = 0.12) or 1 year (19.9 % vs 15.7 %, P = 0.23). Rates of bleeding in patients on AC were 11.6 % within 60 days and 22.5 % within 1 year. Multivariate analysis reflected American Society of Anesthesiologist > 3 and indication for DBE of GI bleeding were independent risk factors for post-DBE bleeding within 1 year. Conclusions Continued antiplatelet use at the time of DBE was not an independent risk factor for bleeding post-DBE at 60 days or 1 year of follow up.
Total elbow arthroplasty for tumors of the distal humerus and elbow
Kruckeberg, Bradley M. , Lee, Dustin R., Rose, Peter S. , Houdek, Matthew T. , Barlow, Jonathan D. , Sanchez-Sotelo, Joaquin, Houdek, Matthew T , Morrey, Mark E. , Sánchez‐Sotelo, Joaquín

Mayo Clinic

Journal of Surgical Oncology | August 23, 2021 | Volume: 124 | Issue: 8 | Pages: 1508-1514

10.1002/jso.26658 | PMID 34424539 Get It

AbstractIntroductionThe elbow is a rare location for primary and metastatic tumors in the upper extremity. The goal of reconstruction is to provide painless motion and stability for hand function. Total elbow arthroplasty (TEA) is commonly utilized, with either off‐the‐self components, modular segmental endoprosthesis, or allograft‐prosthesis composites (APC). The purpose of this study was to analyze and compare commonly utilized elbow reconstructions and report outcomes of (1) patient function and (2) implant survival and complications.MethodsWe reviewed 33 patients (18 females and 15 males) undergoing elbow arthroplasty for reconstruction of an underlying oncologic process including linked TEA (n = 22, 67%), APC (n = 9, 27%), and endoprosthesis (n = 2, 6%). The most common indication was metastatic disease (n = 17, 52%), with 24 patients (73%) presenting with a pathologic fracture.ResultsFive‐year implant survival was following elbow reconstruction was 88%. The mean most recent Mayo Elbow Performance Score and Musculoskeletal Tumor Society Score were 84 ± 18 and 78 ± 15%. Postoperative complications occurred in 15 elbows (45%), most commonly periprosthetic fracture (n = 5, 15%), leading to reoperation in six elbows (18%).ConclusionAlthough elbow arthroplasty is associated with a high incidence of complications, it provides a stable platform for upper extremity function in patients with oncologic processes of the elbow.